Screening flow chart for the systematic review and metaanalysis.
figure
posted on 2023-01-12, 18:34 authored by Nancy Xurui Huang, Qi Yuan, Fang Fang, Bryan P. Yan, John E. SandersonIt includes selecting and exclusion reasons which followed Preferred Reporting Items for Systematic Review and Metaanalysis (PRISMA) statement.
History
Usage metrics
Keywords
statistically significant differenceconverting enzyme inhibitors70 ), p17 ), p14 ), preview manager 5lower mortality ratexlink "> sarsindividuals receiving aceiangiotensin receptor blockersadverse clinical outcomes19 ci (- 3xlink ">clinical outcomessystematic reviewreduced mortality3 softwareshorter durationresults showedprespecified criteriajanuary 2000identified studieshospital stayfemale subjectsdisease severitydirect associatingcochrane libraryasian populationarbs ).28 articles000 01
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC